|
Facebook
Twitter
Linkedin
|
 |
 |
 |
 |
Hologic announces Q307 operating results
Monday, 29 November 1999 19:00 | 
| Medicexchange News - Medicexchange News |
Hologic, Inc., provider of diagnostic and digital imaging systems directed towards women’s health, has announced its results for the quarter ended June 30, 2007.
Hologic, Inc., provider of diagnostic and digital imaging systems directed towards women’s health, has announced its results for the quarter ended June 30, 2007.
Revenues increased 74 per cent, to $535,804,000 compared to revenues of $308,625,000 in the nine months ended June 24, 2006. For the nine months ended June 30, 2007, Hologic recognized net income of $62,468,000, or $1.14 per diluted share, compared with net income of $28,897,000, or $0.61 per diluted share, for the comparable nine-month period in fiscal 2006.
During the third quarter, Hologic recognized as revenue the sale of 328 Selenia full-field digital mammography systems. At June 30, 2007, the Company’s backlog for orders of Selenia was 537 systems, and total backlog for all products was $222.1m.
“We are very pleased with our financial results for the fiscal third quarter, including strong revenue growth, increased earnings and a growing backlog,” said Jack Cumming, Chairman and CEO. “Once again, our sales growth this quarter was highlighted by the continued demand for Selenia, our full field digital mammography system. We believe we are continuing to gain market share in the industries we serve primarily due to our technology leadership. This growth is a testament to the strength of our products and our sales execution, and we believe additional opportunities exist as our brand awareness grows. We are looking forward to continued success in the final quarter of this fiscal year and into next year.”
Beginning in fiscal 2006, the company combined its previously reported mammography and digital detector operating segments to better reflect how the company views its operations and manages its business. Since fiscal 2006, the primary function of the digital detector business is to support the company’s mammography product line.
Revenues increased 74 per cent, to $535,804,000 compared to revenues of $308,625,000 in the nine months ended June 24, 2006. For the nine months ended June 30, 2007, Hologic recognized net income of $62,468,000, or $1.14 per diluted share, compared with net income of $28,897,000, or $0.61 per diluted share, for the comparable nine-month period in fiscal 2006.
During the third quarter, Hologic recognized as revenue the sale of 328 Selenia full-field digital mammography systems. At June 30, 2007, the Company’s backlog for orders of Selenia was 537 systems, and total backlog for all products was $222.1m.
“We are very pleased with our financial results for the fiscal third quarter, including strong revenue growth, increased earnings and a growing backlog,” said Jack Cumming, Chairman and CEO. “Once again, our sales growth this quarter was highlighted by the continued demand for Selenia, our full field digital mammography system. We believe we are continuing to gain market share in the industries we serve primarily due to our technology leadership. This growth is a testament to the strength of our products and our sales execution, and we believe additional opportunities exist as our brand awareness grows. We are looking forward to continued success in the final quarter of this fiscal year and into next year.”
Beginning in fiscal 2006, the company combined its previously reported mammography and digital detector operating segments to better reflect how the company views its operations and manages its business. Since fiscal 2006, the primary function of the digital detector business is to support the company’s mammography product line.
